Stéphane Postic
Directeur Financier/CFO chez MEDINCELL S.A.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Sabri Markabi | M | - | 7 ans | |
| Christophe Douat | M | 60 | 21 ans | |
| Grace Kim | M | - | 1 ans | |
| Julie Alimi | F | - | 3 ans | |
| Philippe Guy | M | - | 14 ans | |
| Antoine Andremont | M | - |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | 24 ans |
| David Heuzé | M | - | 9 ans | |
| Adolfo Lopez-Noriega | M | - | 9 ans | |
| Franck Pouzache | M | - | 4 ans | |
| Pierre-Alain Bandinelli | M | - |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | - |
| Nicolas Merigeau | M | - | - | |
| Christophe Roberge | M | - | 16 ans | |
| Elisabeth Kogan | F | - | 4 ans | |
| Sébastien Magnat | M | - | 8 ans | |
| Sébastien Enault | M | - | - | |
| Richard Malamut | M | 64 | 2 ans | |
| Virginie Lleu | F | - | 8 ans | |
| Tone Kvåle | F | 55 | 2 ans | |
| Nicolas Gourgues | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Anh Nguyen | M | - | 21 ans | |
| Mohammed Khoso Baluch | M | 66 |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | 1 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| France | 21 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Stéphane Postic
- Réseau Personnel
